We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 1

Figure 1. From: Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy.

Symptoms with higher prevalence ratios between survivors and controls (c.f. Table 2, EBRT: symptoms 4, 9, 10, 13, 16, 18, 19, 20 and 21; EBRT+BT: symptoms 4, 5, 9, 10, 12, 13, 15, 16, 18 and 21 and POSTOP: symptoms 16, 18, 19, 20 and 21). Survivors are grouped by treatment and by years from treatment to follow-up. The number of individuals in each group is based on the number answering the question under consideration. Dotted lines indicate the symptom prevalence in the control group (n=243).

C E Olsson, et al. Br J Cancer. 2013 May 28;108(10):1964-1970.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk